Well i try to stay away from nutty stuff. I have had very reliable patients tell me it works so I think they are a nice supplementary thing I can offer. You bill it with an infusion code and a visit code, I don't know it off the top of my head. It doesn't pay great but sometimes it's the only thing that helps. They can also be of assistance when trying to wean narcs. There have been studies to validate ketamine, lidocaine, magnesium, and DHEA infusions for various chronic pain syndromes:
Limdi, NA, Faught, E. (2000) The safety of rapid valproic acid infusion. Epilepsia. 41(10):1342-5.
Lipton, RB, Diamond, S, Reed, M, OQuinn, S, Stewart, WF. (2000) American Migraine StudyII: prevalence, burden and health care utilization for migraine in the United States. Headache. 40:416.
Mathew, NT, Kailasam, J, Meadors L, Chernyschev O, Gentry, P, (2000) Intravenous valproate sodium (depacon)aborts migraine reapidly: a preliminary report, Headache: The journal of head and face pain, Oct:40(9): 720-3
National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov/health_and_medical/disorders/headache.htm
Robbins, LD. (2000) Intravenous valproate for prolonged migraine headache. Headache. 40:427
Sethi, PK (2003)Sodium valproate in migraine therapy. *Neurosciences Today 7(2): 118-20.
Silberstein, SD. (1996) Divalproex sodium in headache: literature review and clinical guidelines. 36:547-555.
Dihydroergotamine (DHEA) references:
Colman, I, Brown, M, Grant, I, Grafstein, E, Roberts, T, Rowe, B. (2005) Parenteral dihydroergotamine for acute migraine headache: asystematic review of the literature. *Annals of Emergency Medicine. (4)45: 393-341
Levetiracetem (Keppra) references:
Micromedex Healthcare series: DRUGDEX Drug Point 2008
Ketamine references:
Baranowski, P, Adamczyk, A, (2007) The implementation of continuous ketamine infusions in neuropathic pain syndrome. *Advances in Palliative Medicine 6: 87-92.
Chung, W, Pharo, G (2007) Successful use of ketamine infusion in the treatment of intractable cancer pain in an outpatient. Journal of Pain and Symptom Management 33(1): 2-5.
Cohen, SP, DeJesus, M. (2004) Ketamine patient-controlled analgesia for dysesthetic central pain. Spinal Cord 42: 425-428.
Edmonds, P. { (1998) The role of ketamine in the management of chronic pain CME Bulletin Palliative Medicine 1(1): 3-6.
Fitzgibbon, E. et al. (2002). Low dose ketamine as an analgesic adjuvant in different pain syndromes: a strategy for conversion form parental to oral ketamine. *Journal of Pain and Symptom Management, 23 (2), 165-170.e
Hocking, G, Cousins, M. (2003) Ketamine in chronic pain management: an evidence-based review. *Anesthesia *Analogue 97:1730-9.
Kronenberg, R (2002). Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. *Journal of Pain and Palliative Care Pharmacotherapy. 16(3):27-35.
Pasero, C (2005) Ketamine: low doses may p[rovide relief for some painful conditions American Journal of Nursing 105(4):60-64.Rauch, D (1998)Use of ketamine in a pain management protocol for repetitive procedures *Pediatrics: Official journal of the American Academy of Pediatrics. 102(2):404.
Subramaniam, K, et al. (2004). *Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. *Anesthesia Analogue. 99: 482-95.
Visser and Schug -The role of ketamine in pain management. Biomed Pharmacother 2006; 60:341-8
Lidocaine references:
Attal, N, Gaude, V, Brasseur, L, Dupuy, M, Guirimand, F, Parkter, F, Bouhassira, d. (2000) Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 54: 564
Ferrini, R, Paice, J (2004) How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain *The Journal of Supportive Oncology 2: 90-94
Baranowski, A ( 1999) A Trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. *Journal of Pain and Symptom Management 17(6): 429-433.
Magnesium references:
Efficacy of intravenous magnesium in neuropathic pain Bril et al British Journal of Anesthesia 89(5)711-14.
Propofol references:
Anwar, MM, Rahman, A (1998) Effect of propofol on perception of pain in mice: mechanisms of action Comp-Biochem-Physiol-A-Mol-Integr-Physuiik, 120(2):249-53.
Bloomstone, J (2007) Propofol: A Novel Treatment for Breaking Migraine Headache (Correspondence). Anesthesiology: 106(2): 405-406.
*
Bostrom, B, Grund, E, Sommers, N, Haase, M, Mill, B (1999) Propofol for Management of Hospice Patients with Cancer Pain. American Society of Clinical Oncology Annual Meeting abstract no. 2300
*
Canavero, S, Bonicalzi, V, Pagni, CA, Castellano, G, Merante, R, Gentile, S, Bradac, GB, Bergui, M, Benna P, Vighetti, S, et al. (1995) *Propofol analgesia in central pain: preliminary clinical observations. *Journal Neurology, 242 (9):561-7.
*
Canavero S, Bonicalzi, V. (2004) *Intravenous subhypnotic propofol in central pain: *A double-blind, placebo-controlled, crossover study. *Clinical Neuropharmacology 27(4): 182-186.
*
Heins, A (2005) Focus On: *Effective Acute Pain Management. American College of Emergency Physicians: Advancing Emergency Care. October: 1-4.
Simmonds, M, (2007) *Propofol Injection for Daily Headache, University of Alberta study. *Clinical Trials.gov
*
Oda, Y, Hamaoka, N, Hiroi, T, Imaoka, S, Hase, I, Tanaka, K, Funae, Y, Ishizaki, T, and Asada, A. (2001). Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. British Journal of Clinical Pharmacology, 51 (3): 281-285.
Zaccheo, M, Bucher, D (2008) Propofol Infusion syndrome Critial Care Nurse. 28(3): 18-25.
*